Archive · 16 Sep 2025
Dr. Reddy's Launches Tegoprazan for Acid-Related GI Issues
Dr. Reddy's, a pharmaceutical company, has introduced a new medicine called Tegoprazan, marketed as PCAB, in India.
This medicine is designed to help people with stomach problems caused by too much acid, such as GERD and stomach ulcers.
The launch is part of Dr. Reddy's focus on treatments for stomach issues.
The medicine will be available in the Indian market.
They've partnered with HK inno.N Corporation for this drug.
Recent studies show that around 38% of people in India have issues with stomach acid.
Dr. Reddy’s Laboratories launched Tegoprazan in India.
Tegoprazan is for acid-related gastrointestinal diseases.
The drug is marketed under the brand name PCAB.
The launch strengthens Dr. Reddy's presence in gastrointestinal treatments.
The drug launch is in partnership with HK inno.N Corporation.
- Who
- Dr. Reddy’s Laboratories Ltd launched Tegoprazan
- What
- Dr. Reddy's launched Tegoprazan for acid-related gastrointestinal diseases.
- When
- The launch was announced on Tuesday, September 16.
- Where
- The drug is launched in the Indian market.
- Why
- To reinforce commitment to innovation in gastrointestinal diseases treatment.
- Company
- Dr. Reddy’s Laboratories Ltd
- Drug Name
- Tegoprazan
- Brand Name
- PCAB
- Indication
- Acid-related gastrointestinal diseases
- Market
- India
- Partnership
- HK inno.N Corporation
